Company Overview
Corporate information, vision, mission, and business model of NuBatt Pte. Ltd.
Company Overview
Corporate Information
| Legal Name | NuBatt Pte. Ltd. |
| Company Registration | 202342218N |
| Jurisdiction | Republic of Singapore |
| Date of Incorporation | 2023 |
| Registered Office | 16 Raffles Quay, #41-01, Hong Leong Building, Singapore 048581 |
| Contact | info@nubatt.com |
NuBatt Pte. Ltd. is a Singapore private limited company focused on the development and commercialisation of advanced nuclear voltaic power systems and related isotope technologies.
Vision
To revolutionise power generation through nuclear voltaic technology, creating perpetual energy solutions that transform nuclear materials from waste into valuable resources.
NuBatt envisions a future where:
Perpetual Operation
Critical systems operate indefinitely without battery replacement or recharging
Resource Transformation
Spent nuclear fuel becomes a resource rather than a liability
Energy Independence
Energy independence is achievable for defence, aerospace, medical, and industrial applications
Clean Continuous Power
Clean, continuous power enables new possibilities across technology sectors
Mission
NuBatt's mission is to:
Develop and commercialise next-generation nuclear batteries that deliver continuous power for up to decades
Create sustainable isotope supply chains for medical, industrial, and energy applications
Enable energy independence for critical infrastructure, defence systems, and remote operations
Transform nuclear waste into productive resources through isotope recycling and repurposing
Core Values
Business Model
NuBatt operates a diversified, vertically integrated business model spanning six complementary revenue streams:
| Revenue Stream | Description |
|---|---|
| Nuclear Batteries | Core products converting radioisotope decay into electricity for defence, aerospace, IoT, and medical applications |
| Medical Isotopes | Production of diagnostic and therapeutic isotopes (Mo-99, Lu-177, Ac-225) for healthcare markets |
| Industrial Isotopes | Supply of isotopes for non-destructive testing, sterilisation, and gauging applications |
| Nuclear Waste Recycling | Conversion of spent nuclear fuel into battery feedstock and valuable isotopes |
| Advanced Carbon Materials | SiC wafers, nanodiamonds, and carbon nano-onions from sustainable organic sources |
| Technology Licensing | Geographic and application-specific licensing of proprietary technologies |
This multi-stream approach provides:
Revenue Diversification
Revenue diversification across multiple markets and customer segments
Supply Chain Synergies
Supply chain synergies where waste recycling feeds battery production
Market Positioning
Market positioning across multiple high-growth technology sectors
Risk Mitigation
Risk mitigation through exposure to different market cycles and applications
For detailed information on each revenue stream, please refer to Section 8 (Revenue Streams) of this Memorandum.
Company Structure
NuBatt Pte. Ltd. is a Singapore entity operating independently with its own intellectual property portfolio, management team, and business operations. The Company has no legacy liabilities and operates as a standalone business.
Organisational Structure
Current Status
Stage
Development and early commercialisation
Employees
Core team in place; expansion planned with this funding
Facilities
Singapore base; production facility location to be determined
Relationship with NDB Inc.
NuBatt Pte. Ltd. holds a technology license from NDB Inc., a Wyoming (USA) corporation that developed foundational nuclear voltaic technology. This relationship is strictly a licensing arrangement.
License Terms
| Aspect | Terms |
|---|---|
| Scope | Worldwide, perpetual, irrevocable, sublicensable |
| Rights | Make, use, sell, offer to sell, import, develop, and commercialise |
| Licensed IP | Three US patents covering nuclear voltaic power sources and electrode technologies |
| Royalty | 2% of after-tax profit |
| Improvements | Any improvements developed by NuBatt are solely owned by NuBatt |
| Protection | NDB cannot assign licensed IP to third parties without NuBatt consent |
| First Refusal | NuBatt holds right of first refusal on any future NDB IP transfers |
Key Distinctions
NuBatt is an independent Singapore company, not a subsidiary or affiliate of NDB Inc.
Own Intellectual Property
NuBatt owns its own intellectual property (6 patent families) in addition to licensed technology
Independent Management
NuBatt has its own management, operations, and business strategy
Financial Independence
NuBatt's financial performance and obligations are independent of NDB
License Only
The only connection is the technology license, which is irrevocable and perpetual
Intellectual Property Position
NuBatt has assembled a strong intellectual property portfolio comprising 9 patent families:
| Application No. | Technology |
|---|---|
| 10202500575S | Liquid Transducer Radioisotope-Powered Nuclear Voltaic System |
| 10202500576V | Gaseous Xenon-Based Nuclear Voltaic Power Source |
| 10202500577W | Noble Gases-Based Nuclear Voltaic Power Source |
| 10202500578Y | Liquid Xenon-Powered Nuclear Voltaic System |
| 10202500617Q | Nuclear Voltaic System |
| 11202403397U | Nuclear Voltaic Power-Source |
This IP portfolio provides comprehensive protection across multiple nuclear voltaic configurations and gives NuBatt freedom to develop and commercialise globally. For detailed IP information, please refer to Section 6 (Technology & IP Portfolio) of this Memorandum.
Singapore as Corporate Home
Singapore provides an optimal base for NuBatt's operations:
- Clear nuclear regulatory framework administered by the National Environment Agency (NEA)
- IAEA member state with established protocols for radioactive materials
- Business-friendly regulatory approach for advanced technology companies
Milestones Achieved
| Date | Milestone |
|---|---|
| 2023 | NuBatt Pte. Ltd. incorporated in Singapore |
| 2024 | Technology license secured from NDB Inc. |
| 2024-2025 | Patent portfolio assigned to NuBatt (6 applications) |
| 2024-2025 | DSO National Laboratories feasibility study completed |
| 2025 | MCNP simulations validated shielding designs |
| 2025 | Dose rate compliance confirmed (4.3× below safety thresholds) |
Near-Term Objectives
With the funding from this Offering, NuBatt aims to achieve the following objectives:
Manufacturing Capability: Establish production facility (Singapore or strategic global location TBD)
Product Development: Advance NuBatt-S1, L1, P1, and Q1 products through development to commercial readiness
Team Expansion: Build engineering, regulatory affairs, and commercial teams
Regulatory Progress: Secure necessary licenses for manufacturing and sales
Customer Development: Expand defence and commercial customer pipeline beyond DSO
Isotope Operations: Establish medical and industrial isotope production capabilities
Contact Information
NuBatt Pte. Ltd. 16 Raffles Quay, #41-01 Hong Leong Building Singapore 048581
Email: info@nubatt.com